| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/07/2005 | WO2003072063A3 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders |
| 04/07/2005 | US20050076395 Transgenic mouse comprising nucleotide sequences coding immunoglobulin domains j, c, v and d for use as bioreactor in biosynthesis of human antibodies; immunodiagnostics |
| 04/07/2005 | US20050075496 Plasmodium falciparum antigens and their vaccine and diagnostic applications |
| 04/07/2005 | US20050075493 Flea synaptic vesicle nucleic acid molecules, proteins and uses thereof |
| 04/07/2005 | US20050075489 DSP-5 dual-specificity phosphatase |
| 04/07/2005 | US20050075488 Interleukin-1 beta antibodies |
| 04/07/2005 | US20050075485 Neisseria meningitidis antigen |
| 04/07/2005 | US20050075308 Methods and compositions for producing antigenic responses |
| 04/07/2005 | US20050075303 Synthetic human papilloma virus genes |
| 04/07/2005 | US20050075298 Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa |
| 04/07/2005 | US20050075268 cell is contacted with a photosentistising agent, cell is irradiated with light to activate photosentisitising agent, the cell is contacted with the molecule to be introduced, particularly for use in cancer treatment, gene therapy and vaccination |
| 04/07/2005 | US20050074884 Identification of peptides that facilitate uptake and cytoplasmic and /or nuclear transport of proteins, DNA and viruses |
| 04/07/2005 | US20050074863 Chemoprotective agent comprising lymphocyte epitopes for use in treatment of cell proliferative disorders |
| 04/07/2005 | US20050074849 Peptides |
| 04/07/2005 | US20050074843 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 04/07/2005 | US20050074823 Monoclonal antibody for use in treatment and prevention of pathogen infection |
| 04/07/2005 | US20050074821 Nerve growth factor specific immunoglobulin for prevention and treatment of chronic pain, nervous system, inflammatory, skin and bone disorders |
| 04/07/2005 | US20050074819 Using ligand gated channel protein to identify modulators for prevention and treatment of tactile allodynia induced after nerve injury |
| 04/07/2005 | US20050074813 Model for testing immunogenicity of peptides |
| 04/07/2005 | US20050074805 Specific markers for diabetes |
| 04/07/2005 | US20050074767 Using transcriptional activity of obesity genes as diagnostic indicator of efficacy of dietetic modulators; treating eating/weight disorders |
| 04/07/2005 | US20050074764 Using presence of point mutations in nicotinic acetylcholine receptor (nACHR) gene as diagnostic/prognosic tool in detction and treatment of indicator of cardiovascular, nervous system, vision and pain disorders |
| 04/07/2005 | US20050074761 Novel means for the diagnosis and therapy of ctcl |
| 04/07/2005 | US20050074758 Prokineticin polypeptides, related compositions and methods |
| 04/07/2005 | US20050074752 Expression vector comprising nucleotide sequences coding viral regulatory protein for use in transformation of muscle cell and generating vaccine for prevention of viral infection |
| 04/07/2005 | US20050074751 Binding viral protein during latency life cycle; binding of antibodies to excellular segments of protein; immobilization; removal of infecting cells; autoimmune disease, lupus, antiarthritic agents |
| 04/07/2005 | US20050074747 Identifying peptide sequences that selectively bind to preferential bio-targets for use in diagnosis of viral disease, diabetes, inflammatory, arthritic, atherosclerotic, cell proliferative, autoimmune and cardiovascular disorders |
| 04/07/2005 | US20050074497 Sustained release delivery systems; contact lens shape; includes vision correction; lower dosage antiangiogenesis therapeutics; reduced local inflammation and/or adverse systemic reactions; macular degeneration; retinopathies |
| 04/07/2005 | US20050074465 HCV fusion proteins with modified NS3 domains |
| 04/07/2005 | US20050074464 Type I allergic diseases; grass pollen |
| 04/07/2005 | US20050074463 Therapeutic vaccination method, mutated peptides of hiv reverse transciptase and their use for vaccination and diagnostic purposes |
| 04/07/2005 | US20050074462 Suppressing IgE immunoglobulin mediated hypersensitivity; transdermal administration |
| 04/07/2005 | US20050074460 Reacting a protein with a hapten (especially a luteinizing hormone releasing hormone peptides derived from E coil, or malaria derived peptides) to produce a hapten-protein conjugate, followed by reacting the hapten-protein conjugate with a polysaccharide |
| 04/07/2005 | US20050074459 Escherichia coli O157:H7 epithelial adhesin |
| 04/07/2005 | US20050074458 Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof |
| 04/07/2005 | US20050074451 Synergistic combination of methotrexate with antibody to alpha 4 integrin or immunologically active antigen binding fragment |
| 04/07/2005 | US20050074450 Compositions comprising neisseria meningitidis antigens from serogroups b and c |
| 04/07/2005 | US20050074427 IL-17 like molecules and uses thereof |
| 04/07/2005 | US20050072430 Nasal devices |
| 04/07/2005 | CA2814269A1 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 04/07/2005 | CA2540706A1 Royal jelly peptide and composition containing the same |
| 04/07/2005 | CA2540283A1 Tumor vaccine |
| 04/07/2005 | CA2539864A1 Hiv pharmaccines |
| 04/07/2005 | CA2539837A1 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 04/07/2005 | CA2539716A1 Compositions and methods to accelerate hematologic recovery |
| 04/07/2005 | CA2539709A1 Novel therapeutic targets in cancer |
| 04/07/2005 | CA2539702A1 Immunotherapy method |
| 04/07/2005 | CA2539432A1 Altering a b cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent |
| 04/07/2005 | CA2538737A1 Treatment of respiratory diseases with anti-il-2 receptor antibodies |
| 04/06/2005 | EP1520860A2 Recombinant protein PilC, method for its production and use thereof |
| 04/06/2005 | EP1520587A1 Allergy vaccine composition, production method thereof and use of same in allergy treatment |
| 04/06/2005 | EP1520032A2 Lung cancer therapeutics and diagnostics |
| 04/06/2005 | EP1520008A1 Animal protein free media for cultivation of cells |
| 04/06/2005 | EP1519957A2 Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair |
| 04/06/2005 | EP1519956A2 Epha2 monoclonal antibodies and methods of use thereof |
| 04/06/2005 | EP1519955A2 Nuclear hormone receptor |
| 04/06/2005 | EP1519953A1 Avian cytokines, such il-12, comprising a p40 and/or p35 subunit(s) |
| 04/06/2005 | EP1519945A2 Novel chemokine binding peptides capable of modulating the biological activity of chemokines |
| 04/06/2005 | EP1519755A2 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue |
| 04/06/2005 | EP1519749A1 Chemotactic factor inhibitor for modulating inflammatory reactions |
| 04/06/2005 | EP1519747A2 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
| 04/06/2005 | EP1519746A1 Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
| 04/06/2005 | EP1519745A1 Method to enhance an immune response of nucleic acid vaccination |
| 04/06/2005 | EP1519742A2 Osteoclast-associated receptor |
| 04/06/2005 | EP1519737A2 Fibrin nanoparticles and uses thereof |
| 04/06/2005 | EP1519736A2 Use of hec1 antagonists in the treatment of proliferative disorders and cancer |
| 04/06/2005 | EP1284997B1 Therapeutic compounds for ovarian cancer |
| 04/06/2005 | EP1212100B1 Delivery system for antidandruff agent |
| 04/06/2005 | EP1162993B1 Use of casb616 polypeptides and polynucleotides for cancer treatment |
| 04/06/2005 | EP1117769B1 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 04/06/2005 | EP1100529B1 Thymosin beta 4 promotes wound repair |
| 04/06/2005 | EP1002093B1 Preparation and use of recombinant influenza a virus m2 constructs and vaccines |
| 04/06/2005 | EP0824594B1 Improved methods for transfecting t cells |
| 04/06/2005 | EP0748219B1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/06/2005 | EP0553244B2 Targeted immunostimulation with bispecific reagents |
| 04/06/2005 | CN1604966A Direct targeting binding proteins |
| 04/06/2005 | CN1604961A Avian embryo particulate biomass for the production of virus antigens |
| 04/06/2005 | CN1604910A Affinity enhancement agents |
| 04/06/2005 | CN1604792A Agents for enhancing the immune response |
| 04/06/2005 | CN1604790A Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi) |
| 04/06/2005 | CN1604789A Thymosin augmentation of genetic immunization |
| 04/06/2005 | CN1604788A High-concentration protein formulations and method of manufacture |
| 04/06/2005 | CN1604787A Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (TFPI) |
| 04/06/2005 | CN1603418A Method for preparing infective hog cholera virus cDNA carrier and use thereof |
| 04/06/2005 | CN1603346A Protein, products containing same, and their use in diagnosis, treatment and /or prevention of SARS related disease |
| 04/06/2005 | CN1603345A Trivalent bispecific antibody and its preparation process and use |
| 04/06/2005 | CN1603342A Caspase-8 interacting proteins |
| 04/06/2005 | CN1603336A Constructs of branched synthetic peptide immunogens with artificial T helper cell epitopes coupled to B cell epitopes |
| 04/06/2005 | CN1602962A Complete virus gene engineering vaccine of aftosa and its preparation method |
| 04/06/2005 | CN1602958A A and O type gene engineering bivalent polypeptide vaccine of livestock foot-and-mouth disease virus and its preparation process |
| 04/06/2005 | CN1602957A Hybrid yeast AIDS vaccine |
| 04/06/2005 | CN1602956A Deactivated BCG for treating disease |
| 04/06/2005 | CN1195860C Delivery of biologically active polypeptides |
| 04/06/2005 | CN1195854C Porcine circovirus recombinant poxvirus vaccine |
| 04/06/2005 | CN1195851C Compounds for immunotherapy of prostate cancer and their use |
| 04/06/2005 | CN1195849C APPIL-a novel protein with growth effects |
| 04/06/2005 | CN1195788C Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
| 04/06/2005 | CN1195779C Double-specificity antibody resisting human ovary cancer and human CD3 |
| 04/06/2005 | CN1195774C HEV antigenic peptide and its method |
| 04/06/2005 | CN1195546C Application of monoclone antibody combined with CD154 for inhibiting rejection of insulin generating transplanted tissue |